Cargando…

Zimbabwe's national AIDS levy: A case study

Background: We conducted a case study of the Zimbabwe National AIDS Trust Fund (‘AIDS Levy’) as an approach to domestic government financing of the response to HIV and AIDS. Methods: Data came from three sources: a literature review, including a search for grey literature, review of government docum...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhat, Nisha, Kilmarx, Peter H., Dube, Freeman, Manenji, Albert, Dube, Medelina, Magure, Tapuwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762022/
https://www.ncbi.nlm.nih.gov/pubmed/26781215
http://dx.doi.org/10.1080/17290376.2015.1123646
_version_ 1782417050164002816
author Bhat, Nisha
Kilmarx, Peter H.
Dube, Freeman
Manenji, Albert
Dube, Medelina
Magure, Tapuwa
author_facet Bhat, Nisha
Kilmarx, Peter H.
Dube, Freeman
Manenji, Albert
Dube, Medelina
Magure, Tapuwa
author_sort Bhat, Nisha
collection PubMed
description Background: We conducted a case study of the Zimbabwe National AIDS Trust Fund (‘AIDS Levy’) as an approach to domestic government financing of the response to HIV and AIDS. Methods: Data came from three sources: a literature review, including a search for grey literature, review of government documents from the Zimbabwe National AIDS Council (NAC), and key informant interviews with representatives of the Zimbabwean government, civil society and international organizations. Findings: The literature search yielded 139 sources, and 20 key informants were interviewed. Established by legislation in 1999, the AIDS Levy entails a 3% income tax for individuals and 3% tax on profits of employers and trusts (which excluded the mining industry until 2015). It is managed by the parastatal NAC through a decentralized structure of AIDS Action Committees. Revenues increased from inception to 2006 through 2008, a period of economic instability and hyperinflation. Following dollarization in 2009, annual revenues continued to increase, reaching US$38.6 million in 2014. By policy, at least 50% of funds are used for purchase of antiretroviral medications. Other spending includes administration and capital costs, HIV prevention, and monitoring and evaluation. Several financial controls and auditing systems are in place. Key informants perceived the AIDS Levy as a ‘homegrown’ solution that provided country ownership and reduced dependence on donor funding, but called for further increased transparency, accountability, and reduced administrative costs, as well as recommended changes to increase revenue. Conclusions: The Zimbabwe AIDS Levy has generated substantial resources, recently over US$35 million per year, and signals an important commitment by Zimbabweans, which may have helped attract other donor resources. Many key informants considered the Zimbabwe AIDS Levy to be a best practice for other countries to follow.
format Online
Article
Text
id pubmed-4762022
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-47620222016-12-01 Zimbabwe's national AIDS levy: A case study Bhat, Nisha Kilmarx, Peter H. Dube, Freeman Manenji, Albert Dube, Medelina Magure, Tapuwa SAHARA J Original Articles Background: We conducted a case study of the Zimbabwe National AIDS Trust Fund (‘AIDS Levy’) as an approach to domestic government financing of the response to HIV and AIDS. Methods: Data came from three sources: a literature review, including a search for grey literature, review of government documents from the Zimbabwe National AIDS Council (NAC), and key informant interviews with representatives of the Zimbabwean government, civil society and international organizations. Findings: The literature search yielded 139 sources, and 20 key informants were interviewed. Established by legislation in 1999, the AIDS Levy entails a 3% income tax for individuals and 3% tax on profits of employers and trusts (which excluded the mining industry until 2015). It is managed by the parastatal NAC through a decentralized structure of AIDS Action Committees. Revenues increased from inception to 2006 through 2008, a period of economic instability and hyperinflation. Following dollarization in 2009, annual revenues continued to increase, reaching US$38.6 million in 2014. By policy, at least 50% of funds are used for purchase of antiretroviral medications. Other spending includes administration and capital costs, HIV prevention, and monitoring and evaluation. Several financial controls and auditing systems are in place. Key informants perceived the AIDS Levy as a ‘homegrown’ solution that provided country ownership and reduced dependence on donor funding, but called for further increased transparency, accountability, and reduced administrative costs, as well as recommended changes to increase revenue. Conclusions: The Zimbabwe AIDS Levy has generated substantial resources, recently over US$35 million per year, and signals an important commitment by Zimbabweans, which may have helped attract other donor resources. Many key informants considered the Zimbabwe AIDS Levy to be a best practice for other countries to follow. Taylor & Francis 2016-01-18 /pmc/articles/PMC4762022/ /pubmed/26781215 http://dx.doi.org/10.1080/17290376.2015.1123646 Text en © 2016 The Author(s). Published by Taylor & Francis http://creativecommons.org/licenses/by/4.0/ This work was authored as part of the Contributor's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Original Articles
Bhat, Nisha
Kilmarx, Peter H.
Dube, Freeman
Manenji, Albert
Dube, Medelina
Magure, Tapuwa
Zimbabwe's national AIDS levy: A case study
title Zimbabwe's national AIDS levy: A case study
title_full Zimbabwe's national AIDS levy: A case study
title_fullStr Zimbabwe's national AIDS levy: A case study
title_full_unstemmed Zimbabwe's national AIDS levy: A case study
title_short Zimbabwe's national AIDS levy: A case study
title_sort zimbabwe's national aids levy: a case study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762022/
https://www.ncbi.nlm.nih.gov/pubmed/26781215
http://dx.doi.org/10.1080/17290376.2015.1123646
work_keys_str_mv AT bhatnisha zimbabwesnationalaidslevyacasestudy
AT kilmarxpeterh zimbabwesnationalaidslevyacasestudy
AT dubefreeman zimbabwesnationalaidslevyacasestudy
AT manenjialbert zimbabwesnationalaidslevyacasestudy
AT dubemedelina zimbabwesnationalaidslevyacasestudy
AT maguretapuwa zimbabwesnationalaidslevyacasestudy